{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:49:35Z","timestamp":1791247775823,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.antiviral.2013.08.013","type":"journal-article","created":{"date-parts":[[2013,8,28]],"date-time":"2013-08-28T05:01:05Z","timestamp":1377666065000},"page":"238-245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Antibody-dependent enhancement of dengue virus infection is inhibited by SA-17, a doxorubicin derivative"],"prefix":"10.1016","volume":"100","author":[{"given":"Nilda V.","family":"Ayala-Nu\u00f1ez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patsaporn","family":"Jarupathirun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne J.F.","family":"Kaptein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Neyts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanda M.","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2013.08.013_b0005","doi-asserted-by":"crossref","first-page":"628475","DOI":"10.1155\/2012\/628475","article-title":"Dengue virus entry as target for antiviral therapy","volume":"2012","author":"Alen","year":"2012","journal-title":"J. Trop. Med."},{"key":"10.1016\/j.antiviral.2013.08.013_b0010","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.virol.2009.01.043","article-title":"Antiviral activity of carbohydrate-binding agents and the role of DC-SIGN in dengue virus infection","volume":"387","author":"Alen","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2013.08.013_b0015","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ymeth.2011.07.009","article-title":"Monitoring virus entry into living cells using DiD-labeled dengue virus particles","volume":"55","author":"Ayala-Nunez","year":"2011","journal-title":"Methods"},{"key":"10.1016\/j.antiviral.2013.08.013_b0020","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.cyto.2005.01.021","article-title":"Proinflammatory factors present in sera from patients with acute dengue infection induce activation and apoptosis of human microvascular endothelial cells: possible role of TNF-alpha in endothelial cell damage in dengue","volume":"30","author":"Cardier","year":"2005","journal-title":"Cytokine"},{"key":"10.1016\/j.antiviral.2013.08.013_b0025","doi-asserted-by":"crossref","first-page":"e721","DOI":"10.1371\/journal.pntd.0000721","article-title":"Structural optimization and de novo design of dengue virus entry inhibitory peptides","volume":"4","author":"Costin","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.antiviral.2013.08.013_b0030","doi-asserted-by":"crossref","first-page":"e29957","DOI":"10.1371\/journal.pone.0029957","article-title":"Antibodies against the envelope glycoprotein promote infectivity of immature dengue virus serotype 2","volume":"7","author":"da Silva Voorham","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.antiviral.2013.08.013_b0035","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1126\/science.1185181","article-title":"Cross-reacting antibodies enhance dengue virus infection in humans","volume":"328","author":"Dejnirattisai","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2013.08.013_b0040","doi-asserted-by":"crossref","first-page":"7814","DOI":"10.1128\/JVI.74.17.7814-7823.2000","article-title":"Infection of human cells by dengue virus is modulated by different cell types and viral strains","volume":"74","author":"Diamond","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.08.013_b0050","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.3390\/v2122649","article-title":"The complexity of antibody-dependent enhancement of dengue virus infection","volume":"2","author":"Guzman","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2013.08.013_b0055","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/S0140-6736(07)61687-0","volume":"370","author":"Halstead","year":"2007","journal-title":"Dengue Lancet"},{"key":"10.1016\/j.antiviral.2013.08.013_b0060","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0065-3527(03)60011-4","article-title":"Neutralization and antibody-dependent enhancement of dengue viruses","volume":"60","author":"Halstead","year":"2003","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.antiviral.2013.08.013_b0065","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4269\/ajtmh.1983.32.157","article-title":"Comparison of P388D1 mouse macrophage cell line and human monocytes for assay of dengue-2 infection-enhancing antibodies","volume":"32","author":"Halstead","year":"1983","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2013.08.013_b0070","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1084\/jem.146.1.201","article-title":"Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody","volume":"146","author":"Halstead","year":"1977","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2013.08.013_b0080","doi-asserted-by":"crossref","first-page":"830","DOI":"10.4269\/ajtmh.1982.31.830","article-title":"Dengue virus-specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence","volume":"31","author":"Henchal","year":"1982","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2013.08.013_b0085","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.4049\/jimmunol.176.5.2825","article-title":"The dual-specific binding of dengue virus and target cells for the antibody-dependent enhancement of dengue virus infection","volume":"176","author":"Huang","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2013.08.013_b0090","doi-asserted-by":"crossref","first-page":"8353","DOI":"10.1128\/JVI.00696-10","article-title":"Influence of pr-M cleavage on the heterogeneity of extracellular dengue virus particles","volume":"84","author":"Junjhon","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.08.013_b0095","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1128\/AAC.00686-10","article-title":"A derivate of the antibiotic doxorubicin is a selective inhibitor of dengue and yellow fever virus replication in vitro","volume":"54","author":"Kaptein","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.08.013_b0100","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.antiviral.2005.08.006","article-title":"Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephalitic flaviviruses","volume":"69","author":"Lee","year":"2006","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.08.013_b0105","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1126\/science.1153263","article-title":"The flavivirus precursor membrane-envelope protein complex: structure and maturation","volume":"319","author":"Li","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2013.08.013_b0110","doi-asserted-by":"crossref","first-page":"6986","DOI":"10.1073\/pnas.0832193100","article-title":"A ligand-binding pocket in the dengue virus envelope glycoprotein","volume":"100","author":"Modis","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.antiviral.2013.08.013_b0115","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0882-4010(87)90056-8","article-title":"Profiles of antibody-dependent enhancement of dengue virus type 2 infection","volume":"3","author":"Morens","year":"1987","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.antiviral.2013.08.013_b0120","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrmicro1067","article-title":"A structural perspective of the flavivirus life cycle","volume":"3","author":"Mukhopadhyay","year":"2005","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.antiviral.2013.08.013_b0125","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.antiviral.2010.11.008","article-title":"Viral entry inhibitors block dengue antibody-dependent enhancement in vitro","volume":"89","author":"Nicholson","year":"2011","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.08.013_b0130","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1128\/JVI.62.1.20-26.1988","article-title":"Antibody-mediated growth of influenza A NWS virus in macrophagelike cell line P388D1","volume":"62","author":"Ochiai","year":"1988","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.08.013_b0135","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0166-3542(03)00175-X","article-title":"In vitro and in vivo antiviral properties of sulfated galactomannans against yellow fever virus (BeH111 strain) and dengue 1 virus (Hawaii strain)","volume":"60","author":"Ono","year":"2003","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.08.013_b0140","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.antiviral.2011.10.002","article-title":"Celgosivir treatment misfolds dengue virus NS1 protein, induces cellular pro-survival genes and protects against lethal challenge mouse model","volume":"92","author":"Rathore","year":"2011","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2013.08.013_b0145","doi-asserted-by":"crossref","first-page":"e1000718","DOI":"10.1371\/journal.ppat.1000718","article-title":"Immature dengue virus: a veiled pathogen?","volume":"6","author":"Rodenhuis-Zybert","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2013.08.013_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(12)61428-7","article-title":"Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial","author":"Sabchareon","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2013.08.013_b0155","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1056\/NEJMra1110265","article-title":"Dengue","volume":"366","author":"Simmons","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2013.08.013_b0160","first-page":"308","article-title":"Understanding dengue pathogenesis: implications for vaccine design","volume":"83","author":"Stephenson","year":"2005","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.antiviral.2013.08.013_b0165","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.trstmh.2005.05.003","article-title":"The problem with dengue","volume":"99","author":"Stephenson","year":"2005","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2013.08.013_b0170","doi-asserted-by":"crossref","first-page":"9227","DOI":"10.1128\/JVI.01087-10","article-title":"Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2","volume":"84","author":"Sukupolvi-Petty","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.08.013_b0175","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.4049\/jimmunol.135.3.1981","article-title":"Phagocytosis by mouse peritoneal macrophages plated on monoclonal antibody-coated immune complex-substrates: effects of complexes of different IgG subclasses on Fc receptor functions","volume":"135","author":"Sung","year":"1985","journal-title":"J. Immunol."},{"key":"10.1016\/j.antiviral.2013.08.013_b0180","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/ja.2005.96","article-title":"A new class of semisynthetic anthracycline glycoside antibiotics incorporating a squaric acid moiety","volume":"58","author":"Sztaricskai","year":"2005","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.antiviral.2013.08.013_b0185","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/bjc.1987.190","article-title":"A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity","volume":"56","author":"Twentyman","year":"1987","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.antiviral.2013.08.013_b0190","doi-asserted-by":"crossref","first-page":"e1000244","DOI":"10.1371\/journal.ppat.1000244","article-title":"Dissecting the cell entry pathway of dengue virus by single-particle tracking in living cells","volume":"4","author":"van der Schaar","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2013.08.013_b0195","doi-asserted-by":"crossref","first-page":"12019","DOI":"10.1128\/JVI.00300-07","article-title":"Characterization of the early events in dengue virus cell entry by biochemical assays and single-virus tracking","volume":"81","author":"van der Schaar","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.08.013_b0205","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1128\/AAC.01148-08","article-title":"A small-molecule dengue virus entry inhibitor","volume":"53","author":"Wang","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2013.08.013_b0210","doi-asserted-by":"crossref","first-page":"8698","DOI":"10.1128\/JVI.79.14.8698-8706.2005","article-title":"Castanospermine, a potent inhibitor of dengue virus infection in vitro and in vivo","volume":"79","author":"Whitby","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.08.013_b0215","unstructured":"World Health Organization, 2012. Dengue and severe dengue, Fact sheet N 117. 2012."},{"key":"10.1016\/j.antiviral.2013.08.013_b0220","unstructured":"World Health Organization, DengueNet. 2012."},{"key":"10.1016\/j.antiviral.2013.08.013_b0225","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1128\/JVI.76.8.3596-3604.2002","article-title":"Antiviral effects of an iminosugar derivative on flavivirus infections","volume":"76","author":"Wu","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.08.013_b0230","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1099\/vir.0.2008\/002535-0","article-title":"Functional importance of dengue virus maturation: infectious properties of immature virions","volume":"89","author":"Zybert","year":"2008","journal-title":"J. Gen. Virol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354213002210?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354213002210?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T04:20:09Z","timestamp":1688444409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354213002210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0166354213002210"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2013.08.013","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibody-dependent enhancement of dengue virus infection is inhibited by SA-17, a doxorubicin derivative","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2013.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}